However, when considering acute leukemias and cancers that originate from transformation of more immature progenitor cells largely preserving the properties of the “original” cell phenotype, it would be expected that this signaling pathway would be also active in CD34‐positive ALL. The gene discussed is CD34; the disease is cancer.